1. United States Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: major
Theravance Biopharma, Inc.

Theravance Biopharma, Inc.

14.90
EUR
0.00
(0.00%)
0.91EPS
16.16P/E
773.17MMarket Cap
Nov 10Next Earn

Income Statement (USD)

Income Statement APIChatGPT
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2012
12/31/2013
12/31/2014
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
130
- -
12
42
49
15
60
73
72
55
51
57
64
107
+ Sales & Services Revenue
130
- -
12
42
49
15
60
73
72
55
51
57
64
107
- Cost of Revenue
- -
- -
4
5
3
6
1
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
4
5
3
6
1
- -
- -
- -
- -
- -
- -
- -
Gross Profit
130
- -
8
37
46
9
60
73
72
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
140
157
240
219
226
269
298
325
369
293
130
111
107
111
+ Selling, General & Admin
26
36
72
90
85
96
97
106
109
99
67
70
69
74
+ Research & Development
114
121
169
129
142
174
201
219
261
194
63
41
38
37
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-10
-156
-233
-182
-180
-260
-239
-252
-298
-238
-79
-53
-42
-4
- Non-Operating (Income) Loss
- -
- -
-2
-1
- -
12
-13
-10
6
28
14
-4
2
-133
+ Interest Expense, Net
- -
- -
-2
-1
- -
4
-1
23
4
7
-2
-7
-2
-8
+ Interest Expense
- -
- -
- -
- -
1
9
10
32
9
9
6
2
3
2
- Interest Income
- -
- -
2
1
1
5
12
8
4
1
9
9
5
10
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
8
-11
-34
2
20
16
3
5
-125
Pretax Income
-10
-156
-231
-181
-181
-272
-226
-242
-303
-265
-93
-49
-45
129
- Income Tax Expense (Benefit)
- -
- -
6
1
10
14
-11
-5
-9
- -
- -
6
12
23
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-10
-156
-237
-182
-191
-285
-216
-236
-295
-265
-93
-55
-56
106
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
-17
-66
-965
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
17
66
965
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
-34
-131
-1,930
- -
- -
- -
Income (Loss) Incl. MI
-10
-156
-237
-182
-191
-285
-216
-236
-278
-199
872
-55
-56
106
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-10
-156
-237
-182
-191
-285
-216
-236
-278
-199
872
-55
-56
106
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-10
-156
-237
-182
-191
-285
-216
-236
-278
-199
872
-55
-56
106
EBIT
-10
-156
-233
-182
-180
-260
-239
-252
-298
-258
-92
-56
-47
-4
EBITDA
-6
-154
-229
-179
-177
-256
-236
-246
-291
-249
-85
-52
-43
-1
EBITDA Margin (%)
-4.86
-67,978.32
-1,961.54
-424.7
-364.55
-1,664.47
-390.24
-334.68
-404.49
-450.52
-165.41
-90.17
-67.31
-0.74
EBITA
-10
- -
-232
- -
- -
-260
- -
- -
- -
-258
- -
- -
- -
- -
Gross Margin (%)
100
100
65.28
88.95
94.05
60.81
98.82
100
100
- -
- -
- -
- -
- -
Operating Margin (%)
-7.36
-69,152.21
-1,989.55
-431.8
-370.96
-1,690.65
-395.48
-343.14
-414.19
-429.65
-154.09
-92.8
-65.91
-3.35
Profit Margin (%)
-7.36
-69,152.21
-2,028.05
-432.56
-391.94
-1,854.97
-357.01
-322.08
-386.9
-360.55
1,698.54
-96.11
-87.63
98.54
Sales per Employee
553,809
837
40,725
134,588
153,949
45,253
166,309
232,323
200,159
347,868
462,577
580,040
663,722
1,194,044
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
3
3
3
3
3
4
3
6
7
9
7
4
4
3
Basic Weighted Avg Shares
32
32
32
34
45
52
54
56
62
69
74
55
49
50
Basic EPS, GAAP
-0.3
-4.84
-7.46
-5.34
-4.26
-5.45
-3.99
-4.25
-4.46
-2.87
11.85
-1
-1.15
2.1
Basic EPS from Cont Ops
-0.3
-4.84
-7.46
-5.34
-4.26
-5.45
-3.99
-4.25
-4.73
-3.82
-1.26
-1
-1.15
2.1
Diluted Weighted Avg Shares
32
32
32
34
45
52
54
56
62
69
74
55
49
52
Diluted EPS, GAAP
-0.3
-4.84
-7.46
-5.34
-4.26
-5.45
-3.99
-4.25
-4.46
-2.87
11.85
-1
-1.15
2.06
Diluted EPS from Cont Ops
-0.3
-4.84
-7.46
-5.34
-4.26
-5.45
-3.99
-4.25
-4.73
-3.82
-1.26
-1
-1.15
2.06

Balance Sheet (USD)

Balance Sheet APIChatGPT
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2012
12/31/2013
12/31/2014
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
- -
14
275
237
529
379
533
338
393
250
353
134
161
418
+ Cash, Cash Equivalents & STI
- -
- -
255
172
501
349
505
281
293
173
327
102
88
315
+ Cash & Cash Equivalents
- -
- -
89
113
345
89
378
58
81
90
298
40
38
168
+ ST Investments
- -
- -
165
60
156
260
127
223
211
84
29
63
51
148
+ Accounts & Notes Receiv
- -
1
2
37
10
9
16
51
70
58
17
17
68
96
+ Accounts Receivable, Net
- -
1
2
37
10
9
11
22
16
14
17
17
18
46
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
5
29
54
44
- -
- -
50
50
+ Inventories
- -
10
13
10
12
17
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
5
7
7
6
12
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
3
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
5
6
3
4
5
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
3
6
18
5
4
11
7
31
19
9
14
4
8
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
11
62
63
111
63
27
70
76
125
254
248
193
67
+ Property, Plant & Equip, Net
- -
10
10
10
8
10
13
59
60
53
52
45
36
30
+ Property, Plant & Equip
- -
62
64
52
53
57
63
107
105
92
85
67
58
54
- Accumulated Depreciation
- -
52
54
42
44
47
50
48
46
38
33
22
22
24
+ LT Investments & Receivables
- -
- -
51
51
100
42
12
5
13
68
- -
- -
- -
11
+ LT Investments
- -
- -
51
51
100
42
12
5
13
68
- -
- -
- -
11
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
1
1
2
3
11
2
6
3
4
202
203
157
26
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
1
1
2
3
11
2
6
3
4
202
203
157
26
Total Assets
- -
25
338
300
639
441
560
409
469
375
607
382
354
486
+ Payables & Accruals
- -
29
41
49
49
62
48
63
83
41
22
21
21
27
+ Accounts Payable
- -
7
10
19
2
6
9
5
7
3
2
2
2
3
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
6
5
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
22
31
31
47
57
39
58
76
38
20
19
13
20
+ ST Debt
- -
- -
- -
- -
- -
- -
- -
18
29
17
7
4
11
11
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
10
19
17
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
8
10
1
7
4
11
11
+ Other ST Liabilities
- -
8
- -
- -
- -
- -
51
32
12
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
8
- -
- -
- -
- -
43
32
12
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
- -
- -
7
- -
- -
- -
- -
- -
- -
- -
Total Current Liabilities
- -
37
41
49
49
63
99
112
124
59
29
25
32
38
+ LT Debt
- -
- -
- -
- -
223
224
454
493
647
652
45
45
39
32
+ LT Borrowings
- -
- -
- -
- -
223
224
454
445
600
599
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
48
47
53
45
45
39
32
+ Other LT Liabilities
- -
5
7
8
17
40
59
28
2
3
91
99
107
119
+ Accrued Liabilities
- -
5
5
5
4
5
34
7
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
1
2
3
13
35
25
21
2
2
91
99
107
119
Total Noncurrent Liabilities
- -
5
7
8
240
264
513
521
649
655
137
144
147
151
Total Liabilities
- -
42
48
57
289
326
612
633
773
713
166
169
179
189
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
- -
429
565
863
914
961
1,025
1,223
1,387
1,296
1,122
1,141
1,156
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
- -
429
565
863
914
961
1,025
1,223
1,387
1,296
1,122
1,141
1,156
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
- -
-17
-139
-322
-512
-798
-1,012
-1,249
-1,527
-1,726
-854
-909
-966
-860
+ Other Equity
- -
- -
- -
- -
- -
-1
- -
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
- -
-17
290
243
350
115
-52
-224
-304
-339
442
213
176
297
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
-17
290
243
350
115
-52
-224
-304
-339
442
213
176
297
Total Liabilities & Equity
- -
25
338
300
639
441
560
409
469
375
607
382
354
486
Shares Outstanding
32
32
32
38
53
54
56
57
64
74
65
48
49
51
Number of Employees
235
270
287
313
316
340
363
316
359
159
111
99
97
90
Capital Leases - Total
- -
- -
- -
- -
- -
- -
- -
55
57
53
52
49
50
43
Net Debt
- -
- -
-89
-113
-122
135
76
397
538
526
-298
-40
-38
-168
Net Debt to Equity
- -
- -
-30.79
-46.37
-34.84
117.01
-147.96
-177.35
-177.02
-155.47
-67.49
-18.57
-21.53
-56.55
Tangible Common Equity Ratio
- -
-67.66
85.79
80.99
54.79
26.09
-9.21
-54.75
-64.76
-90.33
72.74
55.76
49.57
61.11
Current Ratio
- -
0.38
6.67
4.8
10.73
6.05
5.41
3.03
3.18
4.26
12.31
5.39
5.02
10.93
Cash Conversion Cycle
- -
- -
586.68
-1,423.54
843.79
974.24
4,525.66
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

Cash Flow Statement APIChatGPT
2012 Y
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2012
12/31/2013
12/31/2014
12/31/2015
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-10
-156
-237
-182
-191
-285
-216
-236
-295
-265
-93
-55
-56
106
+ Depreciation & Amortization
3
3
3
3
3
4
3
6
7
9
7
4
4
3
+ Non-Cash Items
22
22
46
48
42
58
40
37
63
60
41
32
21
9
+ Stock-Based Compensation
21
22
43
54
41
49
51
60
63
62
40
25
21
18
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
3
-8
-12
+ Asset Impairment Charge
- -
- -
3
2
- -
9
- -
- -
- -
- -
- -
- -
5
- -
+ Other Non-Cash Adj
- -
- -
- -
-8
- -
- -
-11
-23
- -
-2
1
4
3
2
+ Chg in Non-Cash Work Cap
-134
10
13
-38
47
22
59
-45
-38
-40
42
-8
20
120
+ (Inc) Dec in Accts Receiv
-1
- -
14
-35
27
-8
-1
-15
6
2
-3
-1
-1
-27
+ (Inc) Dec in Inventories
-5
-3
-7
1
-3
-7
-2
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
-3
-12
12
1
-2
-1
-20
13
8
-4
9
-3
+ Inc (Dec) in Accts Payable
-3
6
16
8
1
12
-7
9
10
-41
-17
-7
2
4
+ Inc (Dec) in Other
-125
7
-7
- -
10
24
72
-39
-34
-14
54
4
10
147
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
12
28
-185
- -
- -
- -
Cash from Operating Activities
-119
-121
-175
-169
-99
-201
-113
-238
-250
-208
-187
-27
-12
239
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
2
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
2
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
-3
-3
-3
-3
-2
-2
-7
-3
-7
-3
-1
-2
- -
- -
+ Acq of Fixed Prod Assets
-3
-3
-3
-3
-2
-2
-7
-3
-7
-3
-1
-2
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
78
249
-9
-10
-3
130
99
-132
-200
-3
-4
+ Increase in Capital Stock
- -
- -
- -
79
253
- -
- -
- -
140
108
- -
- -
- -
- -
+ Decrease in Capital Stock
- -
- -
- -
-1
-4
-9
-10
-3
-10
-9
-132
-200
-3
-4
+ Net Change in LT Investment
- -
- -
-102
114
-146
-54
164
-85
17
128
55
-32
13
-105
+ Dec in LT Investment
- -
- -
66
187
91
235
347
339
419
286
158
103
156
143
+ Inc in LT Investment
- -
- -
-169
-73
-238
-289
-183
-424
-402
-158
-103
-135
-143
-248
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
20
5
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
20
5
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
-1
- -
- -
- -
- -
- -
- -
- -
1,098
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1,095
- -
- -
- -
Cash from Investing Activities
-2
-3
-106
111
-148
-56
177
-83
11
124
1,154
-33
12
-105
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
222
- -
229
-2
145
-11
-632
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
222
- -
229
- -
380
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
-2
-235
-11
-632
- -
- -
- -
+ Other Financing Activities
122
124
371
3
8
10
6
7
-12
3
5
1
1
1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
122
124
371
81
479
2
225
1
263
92
-759
-199
-2
-3
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
- -
89
23
232
-256
289
-320
23
8
208
-259
-2
130
EBITDA
-6
-154
-229
-179
-177
-256
-236
-246
-291
-249
-85
-52
-43
-1
EBITDA Margin (%)
-4.86
-67,978.32
-1,961.54
-424.7
-364.55
-1,664.47
-390.24
-334.68
-404.49
-450.52
-165.41
-90.17
-67.31
-0.74
Free Cash Flow
-122
-124
-178
-172
-101
-203
-120
-241
-257
-211
-188
-29
-12
238
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
-20
-5
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
241
Free Cash Flow to Equity
-122
-124
-178
-172
121
-203
109
-244
-112
-222
-817
-28
-12
238
Free Cash Flow per Basic Share
-3.77
-3.83
-5.61
-5.02
-2.26
-3.89
-2.23
-4.34
-4.12
-3.04
-2.55
-0.53
-0.24
4.74
Price/Free Cash Flow
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-21.12
-38.99
3.98
Cash Flow to Net Income
12.44
0.77
0.74
0.93
0.52
0.7
0.52
1.01
0.9
1.04
-0.21
0.49
0.2
2.25
Capital Expenditures
-3
-3
-3
-3
-2
-2
-7
-3
-7
-3
-1
-2
- -
- -